- Home
- Company
- Products
- Outsource Manufacturing
- Press/Media
- Press Releases
- 12/05/2007 - Mission Pharmacal Sells Gold Standard Kidney Stone Diagnostic Tests to Quest Diagnostics
- 8/30/2007 - Mission Pharmacal Sells Citracal®Calcium Brand to Bayer HealthCare
- 7/31/2007 - New Study Finds Tindamax® To Be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
- 5/24/2007 - FDA Approves Tindamax® for Bacterial Vaginosis
- 11/13/2006 - CDC Recommends Tindamax® for the Treatment of Trichomoniasis
- 8/17/2007 - Mission Pharmacal Submits Supplemental New Drug Application for Tindamax® (Tinidazole) as Treatment of Bacterial Vaginosis
- 5/9/2006 - Most Common Curable STD a Significant Public Health Concern When Untreated, May Contribute to Spread of HIV
- 5/8/2006 - Mission Pharmacal Completes Phase III Study of Tindamax® for the Treatment of Bacterial Vaginosis
- 4/20/2006 - Mission Pharmacal Acquires Tindamax®: Treatment for Trichomoniasis, Most Common Non-Viral Sexually Transmitted Disease
- News
- Fact Sheets
- Package Inserts
- Press Releases
- Report an Adverse Event
- Site Map
- Privacy / Legal
- Contact
Now approved for the treatment of bacterial vaginosis, the most common vaginal infection among women of childbearing age in the United States.
